The relationship between symptoms and monoamine oxidase-B densities in the brain of depression and organic depression: A PET study with [11C]SL25.1188

Not Applicable

Recruiting

• Conditions: Major depressive disorder, Organic depression

• Registration Number: JPRN-UMIN000045815
• Lead Sponsor: Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-21
• Last Update Posted: 17 October 2023
• Study Completion: 2024-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Not provided

Exclusion Criteria

I. Patients 1. Subjects undergoing dialysis 2. Subjects with a severe physical complication 3. Subjects with metallic medical device in the body 4. Subjects with severe claustrophobia 5. Subjects who tends to suicide 6. Pregnant women 7. Subjects participating in other clinical trials 8. Subjects who donated blood within 3 months 9. Subjects with allergy to local anesthetics and anticoagulants 10. Subjects taking anticoagulants 11. Subjects taking MAO inhibitors 12. Subjects taking supplements or health foods containing curcumin 13. Subjects taking foods, supplements, or health foods 10 hours before blood sampling 14. Subjects who is considered to be inappropriate to participate in the study II. Healthy volunteers 1. Subjects with any psychiatric disorder 2. Subjects with any organic brain disorder 3. Subjects with substance-related disorders 4. Subjects undergoing dialysis 5. Subjects with a severe physical complication 6. Subjects with metallic medical device in the body 7. Subjects with severe claustrophobia 8. Pregnant women 9. Subjects participating in other clinical trials 10. Subjects who donated blood within 3 months 11. Subjects with allergy to local anesthetics and anticoagulants 12. Subjects taking anticoagulants 13. Subjects taking MAO inhibitors 14. Subjects taking supplements or health foods containing curcumin 15. Subjects taking foods, supplements, or health foods 10 hours before blood sampling 16. Subjects who is considered to be inappropriate to participate in the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified